The best indicator for Pfizer (PFE)
We backtested 366 indicators across daily, weekly and hourly charts on real Pfizer (PFE) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
Fibonacci Pivots
On the weekly chart, this is the strongest risk-adjusted edge we found for Pfizer (PFE) over ~54.2 years — trailing buy-and-hold by 1.8% CAGR.
Best multi-indicator combo
Going long only when all 2 agree was the strongest confluence setup we found for Pfizer (PFE) — trailing buy-and-hold by 4.6% CAGR, out-of-sample. Fewer, higher-conviction trades than any single indicator.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | Fibonacci Pivots ✓ | Weekly | 8.3% | 0.56 | -43.3% | 56.0% | 432 | -1.8% |
| 2 | CCI (200) ✓ | Weekly | 9.7% | 0.55 | -53.6% | 39.1% | 23 | -0.4% |
| 3 | Trend Intensity Index ✓ | Weekly | 9.2% | 0.54 | -51.2% | 62.5% | 16 | -0.9% |
| 4 | SMC: Change of Character ✓ | Weekly | 9.3% | 0.54 | -44.2% | 52.0% | 25 | -0.8% |
| 5 | Positive Volume Index ✓ | Weekly | 8.8% | 0.52 | -56.0% | 65.0% | 20 | -1.3% |
| 6 | EMA 200 Trend ✓ | Weekly | 9.2% | 0.52 | -51.7% | 42.1% | 38 | -0.9% |
| 7 | SMA 200 Trend ✓ | Weekly | 9.0% | 0.52 | -48.0% | 45.8% | 24 | -1.1% |
| 8 | T3 10/40 Cross ✓ | Weekly | 8.3% | 0.52 | -52.1% | 53.8% | 26 | -1.7% |
| 9 | Vegas Tunnel ✓ | Weekly | 8.5% | 0.51 | -46.3% | 36.4% | 33 | -1.6% |
| 10 | Pivot Points (Standard) ✓ | Weekly | 7.0% | 0.51 | -48.2% | 55.2% | 388 | -3.1% |
| 11 | SMA 20/80 Cross ✓ | Weekly | 8.5% | 0.51 | -49.3% | 57.9% | 19 | -1.6% |
| 12 | TRIMA 200 Trend ✓ | Weekly | 8.4% | 0.5 | -50.9% | 39.1% | 23 | -1.7% |
| 13 | T3 15/60 Cross ✓ | Weekly | 7.8% | 0.5 | -53.2% | 61.1% | 18 | -2.2% |
| 14 | Intraday Momentum Index ✓ | Daily | 7.9% | 0.49 | -52.5% | 69.0% | 158 | -2.2% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Pfizer (PFE), Fibonacci Pivots on the weekly timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.